BlackRock Health Sciences... (BME)
NYSE: BME
· Echtzeitkurs · USD
44.86
+0.46 (1.04%)
Zum Schluss: Aug 18, 2026, 3:59 PM
44.86
+0.00%
Vorbörslich: 7:04 AM
BlackRock Health Sciences Trust (BME) Stock Price, Analysis & Data
1.04% (1D)
| Geld | n/a |
| Marktkapitalisierung | 579.78 Mio |
| Umsatz (TTM) | 7.74 Mio |
| Nettogewinn (TTM) | 76.97 Mio |
| Beta | 0.58 |
| EPS (ttm) | 5.98 |
| KGV (TTM) | 7.5 |
| Forward-KGV | n/a |
| KBV (TTM) | 1.02 |
| KUV (TTM) | 74.95 |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 34,978 |
| Ø Vol. (20D) | 45,465 |
| Eröffnung | 44.64 |
| Vortagesschluss | 44.40 |
| Tagesspanne | 44.50 - 44.96 |
| 52-Wk Range | 35.95 - 44.99 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | $3.15 (7.01%) |
| Ex-Dividenden-Datum | 15. Sept. 2026 |
Über BME
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical ...
Branche Asset Management
Sektor Financial Services
IPO Datum Mar 29, 2005
Mitarbeiter n/a
Börse NYSE
Tickersymbol BME
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von BlackRock Health Sciences Trust 77.54 Mio, ein Anstieg von 222.1% im Vergleich zum Vorjahr (24.07 Mio). Der Gewinn lag bei 76.97 Mio, ein Anstieg von 228.16 %.
Finanzberichte
